Skip to main navigation
Skip to search
Skip to main content
UT MD Anderson Cancer Center Home
Help & FAQ
Link opens in a new tab
Search content at UT MD Anderson Cancer Center
Home
Profiles
Research units
Equipment
Research output
Activities
Prizes
Diagnosis and management of mycosis fungoides.
Shira L. Galper
,
Benjamin D. Smith
, Lynn D. Wilson
Cancer Center Support Grant (CCSG) Programs
Radiation Oncology
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Diagnosis and management of mycosis fungoides.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Bexarotene
50%
Carmustine
25%
CD4+ T
25%
Clinical Pathology
25%
Clinical Presentation
25%
Clinical Staging
25%
Clinically Significant
25%
Cutaneous Lymphoma
25%
Cutaneous T-cell Lymphoma
25%
Cytotoxic Chemotherapy
25%
Denileukin Diftitox
25%
Emerging Therapeutics
25%
Emerging Treatments
25%
Erythroderma
25%
Extracorporeal Photochemotherapy
25%
Interferon-α (IFN-α)
25%
Late-onset
25%
Mechlorethamine
25%
Mycosis Fungoides
100%
Nitrogen mustard
25%
Ontak
25%
Optimal Treatment
25%
Pathological Diagnosis
25%
Pathological Staging
25%
Paucity
25%
Photopheresis
25%
Plaque
25%
Poor Prognosis
25%
Psoralen
25%
Radiotherapy
25%
Retinoids
25%
Skin Homing
25%
Skin Lesions
25%
Systemic Therapy
50%
Targretin
50%
Topical Therapy
50%
Treatment Options
25%
Tumor
50%
Ultraviolet-B (UV-B)
25%
Vorinostat
25%
Zolinza
25%
Medicine and Dentistry
Bexarotene
100%
Carmustine
50%
Chlormethine
50%
Cutaneous Lymphoma
25%
Cutaneous T Cell Lymphoma
25%
Cytotoxic Chemotherapy
25%
Denileukin Diftitox
50%
Diseases
25%
Emerging Treatment
25%
Erythroderma
25%
Interferon
25%
Mycosis fungoides
100%
Oral
25%
Photopheresis
50%
Psoralen
25%
Retinoid
25%
Skin Defect
25%
Steroid
25%
Systemic Therapy
50%
T-Helper Cell
25%
Topical Treatment
50%
Total Skin Electron Therapy
25%
Treatment Option
25%
Tumor
50%
Vorinostat
50%